GGrantIndex
Sort

24,576 grants matching microbiome

Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases

$509,746
Matthew S Bogyo · Stanford University · R01 · FY2021 · DK

A Prospective Study of Lifestyle, the Gut Microbiome, and Diverticulitis.

$509,698
Andrew T Chan · Massachusetts General Hospital · R01 · FY2021 · DK

Revealing the role of the cervico-vaginal microbiome in spontaneous preterm birth

$509,631
Michal A Elovitz · University Of Pennsylvania · R01 · FY2015 · NR

Persistent HPV Infection in Women at Risk for Cervix Cancer

$509,450
Robert D. Burk · Albert Einstein College Of Medicine, Inc · U01 · FY2015 · CA

Research Training in Digestive Diseases

$509,417
Raymond T Chung · Massachusetts General Hospital · T32 · FY2016 · DK

Microbial Dysbiosis and TLR2 Activation Contribute to Immune Activation, Inflammation and HIV Persistence in the Context of Opioid Abuse Despite ART Therapy

$509,400
Sabita Roy · University Of Miami School Of Medicine · R01 · FY2020 · DA

Mast cells in skin innate immune defense

$509,367
Anna Di Nardo · University Of California, San Diego · R01 · FY2022 · AI

Mast cells in skin innate immune defense

$509,367
Anna Di Nardo · University Of California, San Diego · R01 · FY2023 · AI

A multi-scale systems biology framework for understanding and engineering the human gut microbiome

$509,125
Ophelia Venturelli · Duke University · R35 · FY2025 · GM

Tracheobronchitis in the Critically Ill

$509,101
Anna Christine Zemke · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL

The skin microbiome in acne

$509,088
Robert L Modlin · University Of California Los Angeles · R01 · FY2021 · AR

The enteric microbiome in HIV-associated chronic immune activation and cardiovascular disease

$509,003
Douglas Kwon · Massachusetts General Hospital · R01 · FY2019 · HL

Hologenomic basis of WNV vector competence in Culex tarsalis

$508,991
Jason L Rasgon · Pennsylvania State University, The · R01 · FY2024 · AI

DECONSTRUCTING INFLAMMATION AND ALTERED MICROBIOTA IN METABOLIC SYNDROME

$508,940
Andrew T Gewirtz · Georgia State University · R01 · FY2021 · DK

Pyruvate oxidase: a molecular determinant of commensalism among the oral microbiome

$508,923
Jens Kreth · Oregon Health & Science University · R01 · FY2023 · DE

Impact of microbiota-derived metabolites on traumatic brain injury-related neurodegeneration

$508,868
Dennis William Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS

Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis

$508,847
Emilia Falcone · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Health promoting effects of high-polyphenol foods may be mediated through gut microbiome

$508,839
Ilya Raskin · Rutgers, The State Univ Of N.J. · R01 · FY2017 · AT

Selective Inhibitors of Pro-Ferroptotic Lipoxygenases - Next Generation Radiomitigators

$508,830
Valerian E Kagan · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AI

TREAT-VCU

$508,748
Arun J Sanyal · Virginia Commonwealth University · U01 · FY2016 · AA

Microbial Dysbiosis in Chronic Lung Allograft Dysfunction

$508,746
Nirmal S Sharma · Brigham And Women'S Hospital · R01 · FY2024 · HL

The NICU Antibiotics and Outcomes (NANO) Trial

$508,740
Michael Morowitz · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HD

A Prospective Study of Lifestyle, the Gut Microbiome, and Diverticulitis.

$508,701
Andrew T Chan · Massachusetts General Hospital · R01 · FY2022 · DK

The role of the mycobiome in cancer

$508,693
Iliyan Dimitrov Iliev · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

The role of the mycobiome in cancer

$508,693
Iliyan Dimitrov Iliev · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA